Benzinga’s Top Pre-Market NASDAQ Gainers (FSII, GERN, ATPG, CRUS)

FSI International Inc FSII rose 7.34% to $3.80 in the pre-market session. FSII’s quarterly revenue jumped 85.80% y/y. Geron Corporation GERN added 6.57% to $6 in pre-market trading. The Food and Drug Administration (FDA) has allowed GERN to continue with the first human clinical trial on its embryonic stem cell-based therapy. ATP Oil & Gas Corporation ATPG moved up 4.83% to $11.07 in pre-market trading. ATPG is among the top 10 small-cap stocks with the highest short interest of 32.6% of its total outstanding shares. Cirrus Logic Inc CRUS gained 3.28% to $20.14 in the pre-market session. CRUS’ VP and CFO Thurman K Case has sold 86,766 CRUS shares at an average price of $20.27 per share. Read more from Benzinga's Company news.